Loading...
Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer
PURPOSE: Small-cell neuroendocrine prostate cancer (SCNPC) exhibits an aggressive clinical course and incidence rates appear to be increasing following resistance to potent androgen receptor (AR) antagonists. Currently, treatment options are limited and few model systems are available to identify ne...
Na minha lista:
Udgivet i: | Clin Cancer Res |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2019
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7124974/ https://ncbi.nlm.nih.gov/pubmed/31806643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0775 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|